Flumequine enhances the in vivo mutagenicity of MeIQx in the mouse liver
Tóm tắt
The combined effects of various carcinogens found in food products are a concern for human health. In the present study, the effects of flumequine (FL) on the in vivo mutagenicity of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in the liver were investigated. Additionally, we attempted to clarify the underlying mechanisms through comprehensive gene analysis using a cDNA microarray. Male gpt delta mice were fed a diet of 0.03 % MeIQx, 0.4 % FL, or 0.03 % MeIQx + 0.4 % FL for 13 weeks. The effects of cotreatment with phenobarbital (PB) were also examined. Treatment with MeIQx alone increased gpt and Spi− mutant frequencies, and cotreatment with FL, but not with PB, further exacerbated these effects, despite the lack of in vivo genotoxicity in mice treated with FL alone. FL caused an increase in Cyp1a2 mRNA levels and a decrease in Ugt1b1 mRNA levels, suggesting that the enhancing effects of FL may be due in part to modification of MeIQx metabolism by FL. Moreover, FL induced an increase in hepatocyte proliferation accompanied by hepatocellular injury. Increases in the mRNA levels of genes encoding cytokines derived from Kupffer cells, such as Il1b and Tnf, and cell cycle-related genes, such as Ccnd1 and Ccne1, suggested that FL treatment increases compensatory cell proliferation. Thus, the present study clearly demonstrated the combined effects of 2 different types of carcinogens known as contaminants in foods.
Tài liệu tham khảo
Ames BN, Shigenaga MK, Gold LS (1993) DNA lesions, inducible DNA repair, and cell division: three key factors in mutagenesis and carcinogenesis. Environ Health Perspect 101(Suppl 5):35–44
Choma I, Grenda D, Malionwska I, Suprynowicz Z (1999) Determination of flumequine and doxycycline in milk by a simple thin-layer chromatographic method. J Chromatogr B Biomed Sci Appl 734:7–14
Counts JL, Sarmiento JI, Harbison ML, Downing JC, McClain RM, Goodman JL (1996) Cell proliferation and global methylation status changes in mouse liver after phenobarbital and/or choline-devoid, methionine-deficient diet administration. Carcinogenesis 17:1251–1257
Greenwood D (1998) Activity of flumequine against Escherichia coli: in vitro comparison with nalidixic and oxolinic acids. Antimicrob Agents Chemother 13:479–483
Hasegawa R, Shirai T, Hakoi K, Takaba K, Iwasaki S, Hoshiya T, Ito N, Nagao M, Sugimura T (1991) Synergistic enhancement of glutathione S-transferase placental form-positive hepatic foci development in diethylnitrosamine-treated rats by combined administration of five heterocyclic amines at low doses. Jpn J Cancer Res 82:1378–1384
Iimuro Y, Fujimoto J (2010) TLRs, NF-κB, JNK, and liver regeneration. Gastroenterol Res Pract 2010:598109
Itoh T, Suzuki T, Nishikawa A, Furukawa F, Takahashi M, Xue W, Sofuni T, Hayashi M (2000) In vivo genotoxicity of 2-amino-3,8-dimethylimidazo[4, 5-f]quinoxaline in lacI transgenic (Big Blue) mice. Mutat Res 468:19–25
JECFA (1998) Evaluation of certain veterinary drug residues in food. Forty-eighth report of the Joint FAO/WHO Expert Committee on food additives. World Health Organ Tech Rep Ser 879:35–43
JECFA (2004) Evaluation of certain veterinary drug residues in food. Sixty-second report of the Joint FAO/WHO Expert Committee on food additives. World Health Organ Tech Rep Ser 925:18–19
Jones HB, Clarke NA, Barrass NC (1993) Phenobarbital-induced hepatocellular proliferation: anti-bromodeoxyuridine and anti-proliferating cell nuclear antigen immunocytochemistry. J Histochem Cytochem 41:21–27
Masumura K, Horiguchi M, Nishikawa A, Umemura T, Kanki K, Kanke Y, Nohmi T (2003) Low dose genotoxicity of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in gpt delta transgenic mice. Mutat Res 541:91–102
Mori Y, Koide A, Kobayashi Y, Furukawa F, Hirose M, Nishikawa A (2003) Effects of cigarette smoke and a heterocyclic amine, MeIQx on cytochrome P-450, mutagenic activation of various carcinogens and glucuronidation in rat liver. Mutagenesis 18:87–93
Nishikawa A, Imazawa T, Kuroiwa Y, Kitamura Y, Kanki K, Ishii Y, Umemura T, Hirose M (2005) Induction of colon tumors in C57BL/6 J mice fed MeIQx, IQ, or PhIP followed by dextran sulfate sodium treatment. Toxicol Sci 84:243–248
Nohmi T, Katoh M, Suzuki H, Matsui M, Yamada M, Watanabe M, Suzuki M, Horiya N, Ueda O, Shibuya T, Ikeda H, Sofuni T (1996) A new transgenic mouse mutagenesis test system using Spi- and 6-thioguanine selections. Environ Mol Mutagen 28:465–470
Nohmi T, Suzuki T, Masumura K (2000) Recent advances in the protocols of transgenic mouse mutation assays. Mutat Res 455:191–215
Ochiai M, Nagaoka H, Wakabayashi K, Tanaka Y, Kim SB, Tada A, Nukaya H, Sugimura T, Nagao M (1993) Identification of N 2-(deoxyguanosin-8-yl)-2-amino-3,8-dimethyl-imidazo[4,5-f]quinoxaline 3′,5′-diphosphate, a major DNA adduct, detected by nuclease P1 modification of the 32P-postlabeling method, in the liver of rats fed MeIQx. Carcinogenesis 14:2165–2170
Ohgaki H, Hasegawa H, Suenaga M, Sato S, Takayama S, Sugimura T (1987) Carcinogenicity in mice of a mutagenic compound, 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) from cooked foods. Carcinogenesis 8:665–668
Okamura T, Ishii Y, Suzuki Y, Inoue T, Tasaki M, Kodama Y, Nohmi T, Mitsumori K, Umemura T, Nishikawa A (2010) Enhancing effects of carbon tetrachloride on in vivo mutagenicity in the liver of mice fed 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx). J Toxicol Sci 35:709–720
Pronk MEJ (2004) Joint FAO/WHO Expert Committee on food additives. In: Toxicological evaluation of certain veterinary drug residues in food. WHO food additives series 53, pp 93–96
Roberts RA, Ganey PE, Ju C, Kamendulis LM, Rusyn I, Klaunig JE (2006) Role of the Kupffer cell in mediating hepatic toxicity and carcinogenesis. Toxicol Sci 96:2-15
Salazar-Montes A, Delgado-Rizo V, Armendariz-Borunda J (2000) Differential gene expression of pro-inflammatory and anti-inflammatory cytokines in acute and chronic liver injury. Hepatol Res 16:181–194
Salazar-Montes A, Ruiz-Corro L, Sandoval-Rodriguez A, Lopez-Reyes A, Armendariz-Borunda J (2006) Increased DNA binding activity of NF-kappaB, STAT-3, SMAD3 and AP-1 in acutely damaged liver. World J Gastroenterol 12:5995–6001
Schut HA, Snyderwine EG (1999) DNA adducts of heterocyclic amine food mutagens: implications for mutagenesis and carcinogenesis. Carcinogenesis 20:353–368
Snyderwine EG, Davis CD, Nouso K, Roller PP, Schut HA (1993) 32P-postlabeling analysis of IQ, MeIQx and PhIP adducts formed in vitro in DNA and polynucleotides and found in vivo in hepatic DNA from IQ-, MeIQx- and PhIP-treated monkeys. Carcinogenesis 14:1389–1395
Solomon MS, Morgenthaler PM, Turesky RJ, Essigmann JM (1996) Mutational and DNA binding specificity of the carcinogen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline. J Biol Chem 271:18368–18374
Sugimura T, Wakabayashi K, Nakagama H, Nagao M (2004) Heterocyclic amines: mutagens/carcinogens produced during cooking of meat and fish. Cancer Sci 95:290–299
Takahashi E, Arimoto S, Okamoto K, Negishi T (2007) Enhancement of phase II enzyme activity by purpurin resulting in the suppression of MeIQx-DNA-adduct formation in mice. Mutat Res 626:128–134
Takayama S, Hasegawa H, Ohgaki H (1989) Combination effects of forty carcinogens administered at low doses to male rats. Jpn J Cancer Res 80:732–736
Wakabayashi K, Ushiyama H, Takahashi M, Nukaya H, Kim SB, Hirose M, Ochiai M, Sugimura T, Nagao M (1993) Exposure to heterocyclic amines. Environ Health Perspect 99:129–134